Cullinan Therapeutics CGEM
NASDAQ CGEM
$14.93 -0.43 (-2.77%)
As of: Oct 1, 2026 · 2:29 PM EDT

Cullinan Therapeutics (CGEM) Accumulated Depreciation (2020 - 2025)

Updated

Cullinan Therapeutics (CGEM) posted Accumulated Depreciation of $969,000 for Q4 2025, up 47.3% from $658,000 a year earlier.

Analysis

Cullinan Therapeutics (CGEM) Accumulated Depreciation (2020 - 2025) Analysis & Trends

Since Q4 2020, Cullinan Therapeutics has reported Accumulated Depreciation for 6 quarters.

  • Annual Accumulated Depreciation has increased for three consecutive years, with a five-year compound annual growth rate of 40.2% (FY2020 to FY2025).
  • In prior years, Cullinan Therapeutics' Accumulated Depreciation was $658,000 in FY2024 (+86.9%), $352,000 in FY2023 (+160.7%), $135,000 in FY2022 (-41.8%) and $232,000 in FY2021 (+29.6%).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn
10 Cullinan Therapeutics 987.71 Mn 987.71 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 969,000.00
Dec 31, 2024 658,000.00
Dec 31, 2023 352,000.00
Dec 31, 2022 135,000.00
Dec 31, 2021 232,000.00
Dec 31, 2020 179,000.00
API Access

Cullinan Therapeutics Accumulated Depreciation API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=accumulated-depreciation&ticker=CGEM&period=max&api_key=YOUR_API_KEY